Blood clots on a chip: New model could improve thromboinflammation treatment
Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.
Apr 3, 2025
0
20
MeSH tree: D12.776.124.125
Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.
Apr 3, 2025
0
20
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every once in a while, we stumble upon something unexpected—something that completely changes the way we ...
Thousands of Minnesotans remain exhausted and disabled after their COVID-19 illnesses, but why they got "long COVID" while millions of others who got sick did not remains a mystery.
Mar 19, 2025
0
14
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a decades-old medication used by most hospitals in the U.S. and could hold significant advantages ...
Mar 13, 2025
0
18
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Mar 6, 2025
0
16
Using an animal model of multiple sclerosis (MS), researchers at the National Institutes of Health (NIH) have created a four-dimensional brain map that reveals how lesions similar to those seen in human MS form. These findings, ...
Feb 27, 2025
0
29
The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and Lancet Neurology—the ...
Feb 18, 2025
0
18
For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful thrombectomy results in improved likelihood of excellent outcome (modified Rankin scale score 0 to ...
Feb 18, 2025
0
8
Researchers at McMaster University have made a discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose blood thinners.
Feb 12, 2025
0
75
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented ...
Feb 8, 2025
0
20